No Cover Image

Journal article 623 views 280 downloads

Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme

Steve Bain Orcid Logo, Brian B. Hansen, Samuel J. P. Malkin, Solomon Nuhoho, William J. Valentine, Barrie Chubb, Barnaby Hunt, Matthew Capehorn

Diabetes Therapy, Volume: 11, Issue: 1, Pages: 259 - 277

Swansea University Author: Steve Bain Orcid Logo

  • 52765.pdf

    PDF | Version of Record

    Released under the terms of a Creative Commons Attribution-NonCommercial 4.0 International License (CC-BY-NC).

    Download (937.3KB)

Check full text

DOI (Published version): 10.1007/s13300-019-00736-6

Published in: Diabetes Therapy
ISSN: 1869-6953 1869-6961
Published: Springer Science and Business Media LLC 2020
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa52765
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2019-11-18T13:14:14Z
last_indexed 2020-10-29T04:06:58Z
id cronfa52765
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2020-10-28T16:59:46.9787878</datestamp><bib-version>v2</bib-version><id>52765</id><entry>2019-11-18</entry><title>Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme</title><swanseaauthors><author><sid>5399f4c6e6a70f3608a084ddb938511a</sid><ORCID>0000-0001-8519-4964</ORCID><firstname>Steve</firstname><surname>Bain</surname><name>Steve Bain</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2019-11-18</date><deptcode>BMS</deptcode><abstract/><type>Journal Article</type><journal>Diabetes Therapy</journal><volume>11</volume><journalNumber>1</journalNumber><paginationStart>259</paginationStart><paginationEnd>277</paginationEnd><publisher>Springer Science and Business Media LLC</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>1869-6953</issnPrint><issnElectronic>1869-6961</issnElectronic><keywords/><publishedDay>1</publishedDay><publishedMonth>1</publishedMonth><publishedYear>2020</publishedYear><publishedDate>2020-01-01</publishedDate><doi>10.1007/s13300-019-00736-6</doi><url/><notes/><college>COLLEGE NANME</college><department>Biomedical Sciences</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>BMS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2020-10-28T16:59:46.9787878</lastEdited><Created>2019-11-18T10:11:37.8872651</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Steve</firstname><surname>Bain</surname><orcid>0000-0001-8519-4964</orcid><order>1</order></author><author><firstname>Brian B.</firstname><surname>Hansen</surname><order>2</order></author><author><firstname>Samuel J. P.</firstname><surname>Malkin</surname><order>3</order></author><author><firstname>Solomon</firstname><surname>Nuhoho</surname><order>4</order></author><author><firstname>William J.</firstname><surname>Valentine</surname><order>5</order></author><author><firstname>Barrie</firstname><surname>Chubb</surname><order>6</order></author><author><firstname>Barnaby</firstname><surname>Hunt</surname><order>7</order></author><author><firstname>Matthew</firstname><surname>Capehorn</surname><order>8</order></author></authors><documents><document><filename>52765__16190__0b8b9377e899452588633880c1b6294a.pdf</filename><originalFilename>52765.pdf</originalFilename><uploaded>2019-12-31T16:18:17.2205082</uploaded><type>Output</type><contentLength>959793</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>Released under the terms of a Creative Commons Attribution-NonCommercial 4.0 International License (CC-BY-NC).</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>https://creativecommons.org/licenses/by-nc/4.0/</licence></document></documents><OutputDurs/></rfc1807>
spelling 2020-10-28T16:59:46.9787878 v2 52765 2019-11-18 Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme 5399f4c6e6a70f3608a084ddb938511a 0000-0001-8519-4964 Steve Bain Steve Bain true false 2019-11-18 BMS Journal Article Diabetes Therapy 11 1 259 277 Springer Science and Business Media LLC 1869-6953 1869-6961 1 1 2020 2020-01-01 10.1007/s13300-019-00736-6 COLLEGE NANME Biomedical Sciences COLLEGE CODE BMS Swansea University 2020-10-28T16:59:46.9787878 2019-11-18T10:11:37.8872651 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Steve Bain 0000-0001-8519-4964 1 Brian B. Hansen 2 Samuel J. P. Malkin 3 Solomon Nuhoho 4 William J. Valentine 5 Barrie Chubb 6 Barnaby Hunt 7 Matthew Capehorn 8 52765__16190__0b8b9377e899452588633880c1b6294a.pdf 52765.pdf 2019-12-31T16:18:17.2205082 Output 959793 application/pdf Version of Record true Released under the terms of a Creative Commons Attribution-NonCommercial 4.0 International License (CC-BY-NC). true eng https://creativecommons.org/licenses/by-nc/4.0/
title Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme
spellingShingle Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme
Steve Bain
title_short Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme
title_full Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme
title_fullStr Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme
title_full_unstemmed Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme
title_sort Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme
author_id_str_mv 5399f4c6e6a70f3608a084ddb938511a
author_id_fullname_str_mv 5399f4c6e6a70f3608a084ddb938511a_***_Steve Bain
author Steve Bain
author2 Steve Bain
Brian B. Hansen
Samuel J. P. Malkin
Solomon Nuhoho
William J. Valentine
Barrie Chubb
Barnaby Hunt
Matthew Capehorn
format Journal article
container_title Diabetes Therapy
container_volume 11
container_issue 1
container_start_page 259
publishDate 2020
institution Swansea University
issn 1869-6953
1869-6961
doi_str_mv 10.1007/s13300-019-00736-6
publisher Springer Science and Business Media LLC
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine
document_store_str 1
active_str 0
published_date 2020-01-01T04:05:19Z
_version_ 1763753401915539456
score 10.999161

Similar Items